COMPARATIVE STUDY
EVALUATION STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Add like
Add dislike
Add to saved papers

Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996).

OBJECTIVE: Acute respiratory distress syndrome (ARDS) is a devastating clinical disorder that affects critically ill patients with a wide variety of underlying illnesses. Presently, there is limited population-based information concerning both the impact of ARDS on mortality, and the effects of race and gender on national ARDS mortality rates. In this study, we have attempted to evaluate trends over an 18-yr period in deaths associated with ARDS in the United States.

DESIGN: Case series.

PATIENTS: The Multiple-Cause Mortality Files compiled by the National Center for Health Statistics from 1979-1996 contains information on 38,263,780 decedents. We identified 333,004 decedents who had ARDS.

MEASUREMENTS AND MAIN RESULTS: We calculated age-adjusted annual ARDS mortality rates. The annual age-adjusted mortality rate for ARDS initially increased from 1979 (5.0 deaths per 100,000 individuals) to 1993 (8.1 deaths per 100,000 individuals). From 1993 to 1996, the mortality rate for ARDS decreased significantly to 7.4 deaths per 100,000 individuals. Annual ARDS mortality rates have been continuously higher for men when compared with women and for African-Americans when compared with white decedents and decedents of other racial backgrounds. When decedents were stratified by race and gender, African-American men had the highest ARDS mortality rates in comparison to all other subgroups (mean annual mortality rate of 12.8 deaths per 100,000 African-American men).

CONCLUSIONS: Although the annual ARDS mortality rate is slowly declining in the United States, significant race and gender differences in ARDS mortality exist.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app